Nodus Oncology’s Acquisition of IP Assets From Basilea Pharmaceutica International AG

Giulia Di Palma
Tagged:

Burges Salmon advised biotech company Nodus Oncology on the deal.Nodus Oncology, a novel biotech company, on its strategic acquisition of certain oncology based IP assets from…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here
Giulia Di Palma

Author: Giulia Di Palma

…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here